Looking ahead: Financial strategy and foresight in life sciences

Baker Tilly’s New England life sciences meetup

As the life sciences industry continues to evolve, financial leaders are grappling with a growing set of complexities—from constrained access to capital and shifting reimbursement models to increasingly rigorous audit expectations and compliance requirements. Recent tariff changes and growing uncertainty around U.S. trade policy, particularly as former President Trump signals further adjustments, are adding new layers of complexity to supply chains, manufacturing costs, and long-term capital planning. Meanwhile, potential reductions in NIH funding raise stewardship and grant management concerns, particularly for early-stage and research-driven companies. Coupled with an unclear future for enforcement of regulations like the Foreign Corrupt Practices Act (FCPA), organizations must navigate an environment marked by rising costs, global uncertainty, and shifting compliance expectations.

For organizations at every stage of growth, long-term success demands more than just innovation at the bench—it requires strategic, integrated financial planning and the agility to adjust forecasting models as external forces continue to shift.

Join Baker Tilly’s life sciences specialists for an interactive panel discussion on the financial, regulatory, and operational trends shaping the industry. Our professionals will share insights from real client experiences and offer practical recommendations for navigating today’s challenges while planning for sustainable growth.

Discussion topics will include:

• The current state of capital markets and what funding trends mean for financial strategy and forecasting
• Developing dynamic financial plans that align with organizational lifecycle, investor expectations, and regulatory shifts
• Leveraging financial data and digital tools to support compliance, decision-making, and performance evaluation

Who should attend

C-suite executives, leadership teams, and other professionals within life sciences organizations seeking insights on how to navigate challenges and seize opportunities.

Learning objectives

By the end of this session, participants will be able to:

• Assess how evolving financial, regulatory trends and trade trends are impacting priorities in the life sciences sector.
• Identify strategies to build a more proactive financial infrastructure that accounts for shifting government funding, tariffs, and regulatory uncertainty.
• Evaluate how integrated financial planning and technology can support organizational goals, mitigate risk, and improve stakeholder confidence amid external pressures.